Safety and Tolerability of Pioglitazone-Azilsartan in Subjects With Type 2 Diabetes
Status:
Terminated
Trial end date:
2007-05-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine the safety and tolerability of
pioglitazone-azilsartan, once daily (QD), in patients with type 2 diabetes mellitus.